415 related articles for article (PubMed ID: 32732368)
1. Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching.
Lee SW; Ha EK; Yeniova AÖ; Moon SY; Kim SY; Koh HY; Yang JM; Jeong SJ; Moon SJ; Cho JY; Yoo IK; Yon DK
Gut; 2021 Jan; 70(1):76-84. PubMed ID: 32732368
[TBL] [Abstract][Full Text] [Related]
2. Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Are Associated With Reduced Risk of SARS-CoV-2 Infection Without Comorbidities Including Diabetes, Hypertension, and Dyslipidemia: A Propensity Score-Matched Nationwide Cohort Study.
Kim B; Jung JH; Han K; Kang S; Lee E; Chung H; Kim SG; Cho SJ
J Korean Med Sci; 2023 Apr; 38(13):e99. PubMed ID: 37012686
[TBL] [Abstract][Full Text] [Related]
3. Comparative risk of incidence and clinical outcomes of COVID-19 among proton pump inhibitor and histamine-2 receptor antagonist short-term users: a nationwide retrospective cohort study.
Park J; You SC; Cho J; Park CH; Shin WG; Park RW; In Seo S
BMC Pharmacol Toxicol; 2022 Jan; 23(1):9. PubMed ID: 35039078
[TBL] [Abstract][Full Text] [Related]
4. Association between mental illness and COVID-19 susceptibility and clinical outcomes in South Korea: a nationwide cohort study.
Lee SW; Yang JM; Moon SY; Yoo IK; Ha EK; Kim SY; Park UM; Choi S; Lee SH; Ahn YM; Kim JM; Koh HY; Yon DK
Lancet Psychiatry; 2020 Dec; 7(12):1025-1031. PubMed ID: 32950066
[TBL] [Abstract][Full Text] [Related]
5. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
[TBL] [Abstract][Full Text] [Related]
6. Use of proton pump inhibitors are associated with higher mortality in hospitalized patients with COVID-19.
Wu S; Jin Z; Peng C; Li D; Cheng Y; Zhu R; He J; Wu C
J Glob Health; 2022; 12():05005. PubMed ID: 35198150
[TBL] [Abstract][Full Text] [Related]
7. Proton Pump Inhibitor Use Is Not Strongly Associated With SARS-CoV-2 Related Outcomes: A Nationwide Study and Meta-analysis.
Israelsen SB; Ernst MT; Lundh A; Lundbo LF; Sandholdt H; Hallas J; Benfield T
Clin Gastroenterol Hepatol; 2021 Sep; 19(9):1845-1854.e6. PubMed ID: 33989790
[TBL] [Abstract][Full Text] [Related]
8. Allergic disorders and susceptibility to and severity of COVID-19: A nationwide cohort study.
Yang JM; Koh HY; Moon SY; Yoo IK; Ha EK; You S; Kim SY; Yon DK; Lee SW
J Allergy Clin Immunol; 2020 Oct; 146(4):790-798. PubMed ID: 32810517
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitors and risk of severe COVID-19 in older people.
Gramont B; Fayolle S; Beltramin D; Bidat N; Boudet J; Chaux R; Grange L; Barrau M; Gagneux-Brunon A; Cathébras P; Killian M; Botelho-Nevers E; Célarier T
Age Ageing; 2024 Apr; 53(4):. PubMed ID: 38619123
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 infection among hospitalised pregnant women and impact of different viral strains on COVID-19 severity in Italy: a national prospective population-based cohort study.
Donati S; Corsi E; Maraschini A; Salvatore MA;
BJOG; 2022 Jan; 129(2):221-231. PubMed ID: 34687585
[TBL] [Abstract][Full Text] [Related]
11. Pregnant women with SARS-CoV-2 infection are at higher risk of death and pneumonia: propensity score matched analysis of a nationwide prospective cohort (COV19Mx).
Martinez-Portilla RJ; Sotiriadis A; Chatzakis C; Torres-Torres J; Espino Y Sosa S; Sandoval-Mandujano K; Castro-Bernabe DA; Medina-Jimenez V; Monarrez-Martin JC; Figueras F; Poon LC
Ultrasound Obstet Gynecol; 2021 Feb; 57(2):224-231. PubMed ID: 33320401
[TBL] [Abstract][Full Text] [Related]
12. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
13. Statin Use and COVID-19 Infectivity and Severity in South Korea: Two Population-Based Nationwide Cohort Studies.
Lee SW; Kim SY; Moon SY; Yoo IK; Yoo EG; Eom GH; Kim JM; Shin JI; Jeong MH; Yang JM; Yon DK
JMIR Public Health Surveill; 2021 Oct; 7(10):e29379. PubMed ID: 34623311
[TBL] [Abstract][Full Text] [Related]
14. The Association Between Proton Pump Inhibitors and COVID-19 is Confounded by Hyperglycemia in a Population-Based Study.
Shafrir A; Benson AA; Katz LH; Hershcovici T; Bitan M; Paltiel O; Calderon-Margalit R; Safadi R; Shauly-Aharonov M
Front Pharmacol; 2022; 13():791074. PubMed ID: 35185561
[No Abstract] [Full Text] [Related]
15. Proton pump inhibitors and gastrointestinal symptoms among patients with COVID-19 infection.
Al-Momani H; Aolaymat I
Ann Med; 2024 Dec; 56(1):2355581. PubMed ID: 38823421
[TBL] [Abstract][Full Text] [Related]
16. Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors.
Almario CV; Chey WD; Spiegel BMR
Am J Gastroenterol; 2020 Oct; 115(10):1707-1715. PubMed ID: 32852340
[TBL] [Abstract][Full Text] [Related]
17. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M;
JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669
[TBL] [Abstract][Full Text] [Related]
18. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
19. Estimating COVID-19 Infection and Severity Risks in Patients with Chronic Rhinosinusitis: A Korean Nationwide Cohort Study.
Lee SW; Kim SY; Moon SY; Yang JM; Ha EK; Jee HM; Shin JI; Cho SH; Yon DK; Suh DI
J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2262-2271.e2. PubMed ID: 33931377
[TBL] [Abstract][Full Text] [Related]
20. Characteristics in Pediatric Patients with Coronavirus Disease 2019 in Korea.
Seon JY; Jeon WH; Bae SC; Eun BL; Choung JT; Oh IH
J Korean Med Sci; 2021 May; 36(20):e148. PubMed ID: 34032033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
